Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
23
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kratz Erica | Chief Reg. & Quality Officer | 4 | $0 | $0 | 2026-09-01 |
| Abu-Absi Susan | Chief Operating Officer | 4 | $0 | $0 | 2026-09-01 |
| Elazzouzi Amy | Vice President, Finance | 30 | $0 | $137.8K | 2026-09-01 |
| Hopkins Janet Jill | Chief Medical Officer | 16 | $0 | $326.3K | 2026-09-01 |
| Person Julie | Chief People Officer | 4 | $0 | $0 | 2026-09-01 |
| Bender Jeremy | Director | 2 | $0 | $0 | 2026-07-07 |
| Kilroy Conor | See Remarks | 10 | $0 | $182.7K | 2026-07-01 |
| Gibney Anthony S | See Remarks | 8 | $245.0K | $90.2K | 2026-06-16 |
| Bitetti Teresa Marie | Director | 4 | $0 | $0 | 2026-06-11 |
| Johnson David Michael | Director | 35 | $2.60M | $0 | 2026-06-11 |
| Mattessich Antony C. | Director | 9 | $0 | $0 | 2026-06-11 |
| Srivastava Sapna | Director | 9 | $0 | $0 | 2026-06-11 |
| Holles Natalie C. | See Remarks | 3 | $0 | $0 | 2026-05-19 |
| Matrix Capital Management Company, LP | 10% Owner | 3 | $29.04M | $39.04M | 2026-05-07 |
| de los Pinos Elisabet | See Remarks | 33 | $0 | $1.41M | 2026-03-02 |
| Plavsic Mark | Chief Technology Officer | 8 | $0 | $246.9K | 2026-03-02 |
| Feder Julie B | Chief Financial Officer | 19 | $0 | $448.1K | 2024-10-18 |
| PAREKH RAJESH B | Director | 3 | $0 | $0 | 2023-06-07 |
| Rich Cadmus | See Remarks | 5 | $0 | $20.8K | 2023-01-19 |
| De Rosch Mark | Chief Operating Officer | 5 | $0 | $13.9K | 2023-01-19 |
| Medicxi Growth I LP | 10% Owner | 10 | $9.94M | $0 | 2021-11-02 |
| GOEL DAVID E. | 10% Owner | 3 | $24.99M | $0 | 2021-11-02 |
| Primiano Christopher Brett | Chief Business Officer | 2 | $0 | $0 | 2021-10-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Abu-Absi Susan | Chief Operating Officer | A Award deriv | 2026-09-01 | 2026-09-01 | 265,487 | — | $0 | 265,487 | SEC↗ |
| Elazzouzi Amy | SVP, Finance & PAO | A Award deriv | 2026-09-01 | 2026-09-01 | 46,460 | — | $0 | 46,460 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award deriv | 2026-09-01 | 2026-09-01 | 116,150 | — | $0 | 116,150 | SEC↗ |
| Kratz Erica | Chief Reg. & Quality Officer | A Award deriv | 2026-09-01 | 2026-09-01 | 199,115 | — | $0 | 199,115 | SEC↗ |
| Person Julie | Chief People Officer | A Award deriv | 2026-09-01 | 2026-09-01 | 212,389 | — | $0 | 212,389 | SEC↗ |
| Abu-Absi Susan | Chief Operating Officer | A Award | 2026-09-01 | 2026-09-01 | 134,513 | — | $0 | 134,513 | SEC↗ |
| Elazzouzi Amy | SVP, Finance & PAO | A Award | 2026-09-01 | 2026-09-01 | 23,540 | — | $0 | 143,600 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award | 2026-09-01 | 2026-09-01 | 58,850 | — | $0 | 380,190 | SEC↗ |
| Kratz Erica | Chief Reg. & Quality Officer | A Award | 2026-09-01 | 2026-09-01 | 100,885 | — | $0 | 100,885 | SEC↗ |
| Person Julie | Chief People Officer | A Award | 2026-09-01 | 2026-09-01 | 107,611 | — | $0 | 107,611 | SEC↗ |
| Kratz Erica | Chief Reg. & Quality Officer | A Award deriv | 2026-09-01 | 2026-09-01 | 199,115 | — | $0 | 199,115 | SEC↗ |
| Kratz Erica | Chief Reg. & Quality Officer | A Award | 2026-09-01 | 2026-09-01 | 100,885 | — | $0 | 100,885 | SEC↗ |
| Elazzouzi Amy | SVP, Finance & PAO | A Award deriv | 2026-09-01 | 2026-09-01 | 46,460 | — | $0 | 46,460 | SEC↗ |
| Elazzouzi Amy | SVP, Finance & PAO | A Award | 2026-09-01 | 2026-09-01 | 23,540 | — | $0 | 143,600 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award deriv | 2026-09-01 | 2026-09-01 | 116,150 | — | $0 | 116,150 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award | 2026-09-01 | 2026-09-01 | 58,850 | — | $0 | 380,190 | SEC↗ |
| Person Julie | Chief People Officer | A Award deriv | 2026-09-01 | 2026-09-01 | 212,389 | — | $0 | 212,389 | SEC↗ |
| Person Julie | Chief People Officer | A Award | 2026-09-01 | 2026-09-01 | 107,611 | — | $0 | 107,611 | SEC↗ |
| Abu-Absi Susan | Chief Operating Officer | A Award deriv | 2026-09-01 | 2026-09-01 | 265,487 | — | $0 | 265,487 | SEC↗ |
| Abu-Absi Susan | Chief Operating Officer | A Award | 2026-09-01 | 2026-09-01 | 134,513 | — | $0 | 134,513 | SEC↗ |
| Bender Jeremy | Director | A Award deriv | 2026-07-07 | 2026-07-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Bender Jeremy | Director | A Award | 2026-07-07 | 2026-07-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kilroy Conor | See Remarks | A Award | 2026-07-01 | 2026-07-01 | 14,858 | — | $0 | 232,693 | SEC↗ |
| Gibney Anthony S | See Remarks | S Sale | 2026-06-16 | 2026-06-16 | 12,824 | $6.42 | $82.3K | 265,354 | SEC↗ |
| Mattessich Antony C. | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Johnson David Michael | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Srivastava Sapna | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Bitetti Teresa Marie | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Mattessich Antony C. | Director | A Award | 2026-06-11 | 2026-06-15 | 15,000 | — | $0 | 38,500 | SEC↗ |
| Johnson David Michael | Director | A Award | 2026-06-11 | 2026-06-15 | 15,000 | — | $0 | 194,167 | SEC↗ |
| Srivastava Sapna | Director | A Award | 2026-06-11 | 2026-06-15 | 15,000 | — | $0 | 38,500 | SEC↗ |
| Bitetti Teresa Marie | Director | A Award | 2026-06-11 | 2026-06-15 | 15,000 | — | $0 | 36,000 | SEC↗ |
| Holles Natalie C. | See Remarks | A Award deriv | 2026-05-19 | 2026-05-19 | 2,169,103 | — | $0 | 2,169,103 | SEC↗ |
| Holles Natalie C. | See Remarks | A Award | 2026-05-19 | 2026-05-19 | 600,118 | — | $0 | 600,118 | SEC↗ |
| Holles Natalie C. | See Remarks | A Award | 2026-05-19 | 2026-05-19 | 553,844 | — | $0 | 1,153,962 | SEC↗ |
| Matrix Capital Management Comp | 10% Owner | S Sale | 2026-05-07 | 2026-05-11 | 6,922,870 | $5.64 | $39.04M | 0 | SEC↗ |
| Kilroy Conor | See Remarks | S Sale | 2026-04-16 | 2026-04-16 | 11,738 | $7.02 | $82.4K | 217,835 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | A Award deriv | 2026-03-02 | 2026-03-03 | 80,472 | — | $0 | 80,472 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award deriv | 2026-03-02 | 2026-03-03 | 160,944 | — | $0 | 160,944 | SEC↗ |
| Plavsic Mark | Chief Technology Officer | A Award deriv | 2026-03-02 | 2026-03-03 | 112,661 | — | $0 | 112,661 | SEC↗ |
| de los Pinos Elisabet | See Remarks | A Award deriv | 2026-03-02 | 2026-03-03 | 249,000 | — | $0 | 249,000 | SEC↗ |
| Gibney Anthony S | See Remarks | A Award deriv | 2026-03-02 | 2026-03-03 | 128,755 | — | $0 | 128,755 | SEC↗ |
| Kilroy Conor | See Remarks | A Award deriv | 2026-03-02 | 2026-03-03 | 112,661 | — | $0 | 112,661 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | A Award | 2026-03-02 | 2026-03-03 | 44,528 | — | $0 | 120,060 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award | 2026-03-02 | 2026-03-03 | 89,056 | — | $0 | 321,340 | SEC↗ |
| Plavsic Mark | Chief Technology Officer | A Award | 2026-03-02 | 2026-03-03 | 62,339 | — | $0 | 243,736 | SEC↗ |
| de los Pinos Elisabet | See Remarks | A Award | 2026-03-02 | 2026-03-03 | 166,000 | — | $0 | 575,815 | SEC↗ |
| Gibney Anthony S | See Remarks | A Award | 2026-03-02 | 2026-03-03 | 71,245 | — | $0 | 278,178 | SEC↗ |
| Kilroy Conor | See Remarks | A Award | 2026-03-02 | 2026-03-03 | 62,339 | — | $0 | 229,573 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2026-02-17 | 2026-02-17 | 47,648 | $5.06 | $241.1K | 409,815 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | S Sale | 2026-02-17 | 2026-02-17 | 8,549 | $5.06 | $43.3K | 75,532 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | S Sale | 2026-02-17 | 2026-02-17 | 20,401 | $5.06 | $103.2K | 232,284 | SEC↗ |
| Plavsic Mark | Chief Technology Officer | S Sale | 2026-02-17 | 2026-02-17 | 15,890 | $5.05 | $80.2K | 181,397 | SEC↗ |
| Kilroy Conor | See Remarks | S Sale | 2026-02-17 | 2026-02-17 | 12,079 | $5.05 | $61.0K | 167,234 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2026-01-20 | 2026-01-20 | 16,928 | $4.86 | $82.3K | 457,463 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | S Sale | 2026-01-20 | 2026-01-20 | 1,581 | $4.86 | $7.7K | 84,081 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | S Sale | 2025-11-17 | 2025-11-17 | 17,109 | $5.42 | $92.7K | 252,685 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2025-10-29 | 2025-10-29 | 9,049 | $6.35 | $57.5K | 474,391 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | S Sale | 2025-10-29 | 2025-10-29 | 896 | $6.35 | $5.7K | 85,662 | SEC↗ |
| Plavsic Mark | Chief Technology Officer | S Sale | 2025-10-16 | 2025-10-16 | 12,169 | $6.35 | $77.3K | 197,287 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise deriv | 2025-08-18 | 2025-08-18 | 547 | — | $0 | 0 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise deriv | 2025-08-18 | 2025-08-18 | 2,554 | — | $0 | 0 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise deriv | 2025-08-18 | 2025-08-18 | 2,319 | — | $0 | 0 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise deriv | 2025-08-18 | 2025-08-18 | 1,094 | — | $0 | 0 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise deriv | 2025-08-18 | 2025-08-18 | 4,744 | — | $0 | 0 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise deriv | 2025-08-18 | 2025-08-18 | 547 | — | $0 | 0 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise deriv | 2025-08-18 | 2025-08-18 | 1,094 | — | $0 | 0 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise | 2025-08-18 | 2025-08-18 | 1,094 | $3.16 | $3.5K | 91,961 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise | 2025-08-18 | 2025-08-18 | 2,554 | $5.07 | $12.9K | 83,935 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | S Sale | 2025-08-18 | 2025-08-18 | 7,722 | $6.70 | $51.7K | 86,558 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise | 2025-08-18 | 2025-08-18 | 4,744 | $2.74 | $13.0K | 90,867 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise | 2025-08-18 | 2025-08-18 | 547 | $5.48 | $3.0K | 85,576 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise | 2025-08-18 | 2025-08-18 | 547 | $5.21 | $2.8K | 86,123 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise | 2025-08-18 | 2025-08-18 | 1,094 | $5.48 | $6.0K | 85,029 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | M Exercise | 2025-08-18 | 2025-08-18 | 2,319 | $4.25 | $9.9K | 94,280 | SEC↗ |
| Mattessich Antony C. | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Johnson David Michael | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Srivastava Sapna | Director | A Award deriv | 2025-06-17 | 2025-06-18 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Mattessich Antony C. | Director | A Award | 2025-06-17 | 2025-06-18 | 13,000 | — | $0 | 23,500 | SEC↗ |
| Johnson David Michael | Director | A Award | 2025-06-17 | 2025-06-18 | 13,000 | — | $0 | 179,167 | SEC↗ |
| Srivastava Sapna | Director | A Award | 2025-06-17 | 2025-06-18 | 13,000 | — | $0 | 23,500 | SEC↗ |
| de los Pinos Elisabet | See Remarks | M Exercise deriv | 2025-06-02 | 2025-06-04 | 10,948 | — | $0 | 0 | SEC↗ |
| Gibney Anthony S | See Remarks | A Award deriv | 2025-06-02 | 2025-06-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| de los Pinos Elisabet | See Remarks | F Tax w/h | 2025-06-02 | 2025-06-04 | 9,948 | $6.16 | $61.3K | 483,440 | SEC↗ |
| de los Pinos Elisabet | See Remarks | M Exercise | 2025-06-02 | 2025-06-04 | 10,948 | $5.07 | $55.5K | 493,388 | SEC↗ |
| Gibney Anthony S | See Remarks | A Award | 2025-06-02 | 2025-06-04 | 150,000 | — | $0 | 206,933 | SEC↗ |
| Gibney Anthony S | See Remarks | P Buy deriv | 2025-05-16 | 2025-05-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Johnson David Michael | Director | P Buy deriv | 2025-05-16 | 2025-05-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Gibney Anthony S | See Remarks | S Sale | 2025-05-16 | 2025-05-20 | 1,519 | $5.15 | $7.8K | 56,933 | SEC↗ |
| Gibney Anthony S | See Remarks | P Buy | 2025-05-16 | 2025-05-20 | 50,000 | $4.90 | $245.0K | 58,452 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2025-05-16 | 2025-05-20 | 20,000 | $4.90 | $98.0K | 166,167 | SEC↗ |
| Kilroy Conor | See Remarks | S Sale | 2025-04-16 | 2025-04-16 | 7,162 | $5.49 | $39.3K | 179,313 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | S Sale | 2025-04-16 | 2025-04-16 | 897 | $5.49 | $4.9K | 81,381 | SEC↗ |
| Bitetti Teresa Marie | Director | A Award deriv | 2025-03-31 | 2025-04-02 | 29,000 | — | $0 | 29,000 | SEC↗ |
| Bitetti Teresa Marie | Director | A Award | 2025-03-31 | 2025-04-02 | 21,000 | — | $0 | 21,000 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2025-02-18 | 2025-02-18 | 20,221 | $7.75 | $156.7K | 482,440 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | S Sale | 2025-02-18 | 2025-02-18 | 2,534 | $7.75 | $19.6K | 269,794 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | S Sale | 2025-02-18 | 2025-02-18 | 1,404 | $7.75 | $10.9K | 82,278 | SEC↗ |
| Plavsic Mark | Chief Technology Officer | S Sale | 2025-02-18 | 2025-02-18 | 2,151 | $7.75 | $16.7K | 209,456 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | A Award deriv | 2025-02-03 | 2025-02-04 | 29,760 | — | $0 | 29,760 | SEC↗ |
| Kilroy Conor | See Remarks | A Award deriv | 2025-02-03 | 2025-02-04 | 59,525 | — | $0 | 59,525 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award deriv | 2025-02-03 | 2025-02-04 | 79,365 | — | $0 | 79,365 | SEC↗ |
| Plavsic Mark | Chief Technology Officer | A Award deriv | 2025-02-03 | 2025-02-04 | 59,525 | — | $0 | 59,525 | SEC↗ |
| de los Pinos Elisabet | See Remarks | A Award deriv | 2025-02-03 | 2025-02-04 | 255,680 | — | $0 | 255,680 | SEC↗ |
| Elazzouzi Amy | Senior Vice President, Finan | A Award | 2025-02-03 | 2025-02-04 | 45,240 | — | $0 | 83,682 | SEC↗ |
| Kilroy Conor | See Remarks | A Award | 2025-02-03 | 2025-02-04 | 90,475 | — | $0 | 186,475 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award | 2025-02-03 | 2025-02-04 | 120,635 | — | $0 | 272,328 | SEC↗ |
| Plavsic Mark | Chief Technology Officer | A Award | 2025-02-03 | 2025-02-04 | 90,475 | — | $0 | 211,607 | SEC↗ |
| de los Pinos Elisabet | See Remarks | A Award | 2025-02-03 | 2025-02-04 | 194,320 | — | $0 | 502,661 | SEC↗ |
| Elazzouzi Amy | Vice President, Finance | S Sale | 2025-01-21 | 2025-01-21 | 1,001 | $7.67 | $7.7K | 38,442 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2025-01-21 | 2025-01-21 | 15,955 | $7.67 | $122.4K | 304,692 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | S Sale | 2024-11-18 | 2024-11-18 | 11,822 | $9.36 | $110.7K | 151,693 | SEC↗ |
| Elazzouzi Amy | Vice President, Finance | S Sale | 2024-10-29 | 2024-10-29 | 553 | $10.74 | $5.9K | 39,443 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2024-10-29 | 2024-10-29 | 9,200 | $10.74 | $98.8K | 320,647 | SEC↗ |
| de los Pinos Elisabet | See Remarks | M Exercise deriv | 2024-10-18 | 2024-10-18 | 24,992 | — | $0 | 336,171 | SEC↗ |
| Feder Julie B | Chief Financial Officer | M Exercise deriv | 2024-10-18 | 2024-10-21 | 2,631 | — | $0 | 32,359 | SEC↗ |
| Feder Julie B | Chief Financial Officer | M Exercise deriv | 2024-10-18 | 2024-10-21 | 5,000 | — | $0 | 120,547 | SEC↗ |
| Feder Julie B | Chief Financial Officer | M Exercise deriv | 2024-10-18 | 2024-10-21 | 17,500 | — | $0 | 68,257 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2024-10-18 | 2024-10-18 | 24,992 | $12.04 | $300.9K | 329,847 | SEC↗ |
| de los Pinos Elisabet | See Remarks | M Exercise | 2024-10-18 | 2024-10-18 | 24,992 | $2.74 | $68.5K | 354,839 | SEC↗ |
| Feder Julie B | Chief Financial Officer | M Exercise | 2024-10-18 | 2024-10-21 | 5,000 | $5.48 | $27.4K | 159,407 | SEC↗ |
| Feder Julie B | Chief Financial Officer | M Exercise | 2024-10-18 | 2024-10-21 | 2,631 | $4.25 | $11.2K | 154,407 | SEC↗ |
| Feder Julie B | Chief Financial Officer | M Exercise | 2024-10-18 | 2024-10-21 | 17,500 | $2.74 | $48.0K | 151,776 | SEC↗ |
| Feder Julie B | Chief Financial Officer | S Sale | 2024-10-18 | 2024-10-21 | 25,131 | $12.03 | $302.3K | 134,276 | SEC↗ |
| Plavsic Mark | Chief Technology Officer | S Sale | 2024-10-16 | 2024-10-16 | 7,383 | $9.85 | $72.7K | 121,132 | SEC↗ |
| de los Pinos Elisabet | See Remarks | M Exercise deriv | 2024-09-27 | 2024-10-01 | 5,474 | — | $0 | 0 | SEC↗ |
| de los Pinos Elisabet | See Remarks | M Exercise | 2024-09-27 | 2024-10-01 | 5,474 | $5.76 | $31.5K | 329,847 | SEC↗ |
| Johnson David Michael | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 14,500 | — | $0 | 14,500 | SEC↗ |
| Srivastava Sapna | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 14,500 | — | $0 | 14,500 | SEC↗ |
| Mattessich Antony C. | Director | A Award deriv | 2024-06-20 | 2024-06-24 | 14,500 | — | $0 | 14,500 | SEC↗ |
| Johnson David Michael | Director | A Award | 2024-06-20 | 2024-06-24 | 10,500 | — | $0 | 146,167 | SEC↗ |
| Srivastava Sapna | Director | A Award | 2024-06-20 | 2024-06-24 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Mattessich Antony C. | Director | A Award | 2024-06-20 | 2024-06-24 | 10,500 | — | $0 | 10,500 | SEC↗ |
| Kilroy Conor | General Counsel and Secretar | A Award deriv | 2024-04-02 | 2024-04-04 | 144,000 | — | $0 | 144,000 | SEC↗ |
| Kilroy Conor | General Counsel and Secretar | A Award | 2024-04-02 | 2024-04-04 | 96,000 | — | $0 | 96,000 | SEC↗ |
| de los Pinos Elisabet | See Remarks | A Award deriv | 2024-02-01 | 2024-02-02 | 237,065 | — | $0 | 237,065 | SEC↗ |
| Feder Julie B | Chief Financial Officer | A Award deriv | 2024-02-01 | 2024-02-02 | 103,715 | — | $0 | 103,715 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award deriv | 2024-02-01 | 2024-02-02 | 41,485 | — | $0 | 41,485 | SEC↗ |
| de los Pinos Elisabet | See Remarks | A Award | 2024-02-01 | 2024-02-02 | 162,935 | — | $0 | 324,373 | SEC↗ |
| Feder Julie B | Chief Financial Officer | A Award | 2024-02-01 | 2024-02-02 | 71,285 | — | $0 | 134,276 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award | 2024-02-01 | 2024-02-02 | 28,515 | — | $0 | 163,515 | SEC↗ |
| Feder Julie B | Chief Financial Officer | S Sale | 2024-01-23 | 2024-01-24 | 6,609 | $7.64 | $50.5K | 62,991 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2024-01-23 | 2024-01-24 | 15,853 | $7.64 | $121.1K | 161,438 | SEC↗ |
| Matrix Capital Management Comp | 10% Owner | P Buy | 2023-11-09 | 2023-11-09 | 1,560,000 | $9.00 | $14.04M | 6,922,870 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-11-08 | 2023-11-09 | 10,000 | $7.30 | $73.0K | 75,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-11-08 | 2023-11-09 | 9,601 | $7.30 | $70.1K | 135,667 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-11-08 | 2023-11-09 | 10,000 | $7.30 | $73.0K | 75,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-11-07 | 2023-11-09 | 76,000 | $7.17 | $544.9K | 126,066 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-11-07 | 2023-11-09 | 47,000 | $7.17 | $337.0K | 65,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-11-07 | 2023-11-09 | 47,000 | $7.17 | $337.0K | 65,000 | SEC↗ |
| Feder Julie B | Chief Financial Officer | M Exercise deriv | 2023-11-06 | 2023-11-07 | 3,900 | — | $0 | 85,757 | SEC↗ |
| de los Pinos Elisabet | See Remarks | M Exercise deriv | 2023-11-06 | 2023-11-07 | 3,800 | — | $0 | 361,163 | SEC↗ |
| Feder Julie B | Chief Financial Officer | M Exercise | 2023-11-06 | 2023-11-07 | 3,900 | $2.74 | $10.7K | 73,500 | SEC↗ |
| Feder Julie B | Chief Financial Officer | S Sale | 2023-11-06 | 2023-11-07 | 3,900 | $12.07 | $47.1K | 69,600 | SEC↗ |
| de los Pinos Elisabet | See Remarks | M Exercise | 2023-11-06 | 2023-11-07 | 3,800 | $2.74 | $10.4K | 184,740 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2023-11-06 | 2023-11-07 | 7,449 | $12.03 | $89.6K | 177,291 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award deriv | 2023-11-01 | 2023-11-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Hopkins Janet Jill | Chief Medical Officer | A Award | 2023-11-01 | 2023-11-03 | 135,000 | — | $0 | 135,000 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2023-10-30 | 2023-11-01 | 9,586 | $6.83 | $65.5K | 180,940 | SEC↗ |
| Feder Julie B | Chief Financial Officer | S Sale | 2023-10-30 | 2023-11-01 | 3,385 | $6.82 | $23.1K | 69,600 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-10-04 | 2023-10-05 | 6,566 | $8.61 | $56.5K | 50,066 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-10-03 | 2023-10-05 | 13,500 | $8.27 | $111.6K | 43,500 | SEC↗ |
| Srivastava Sapna | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 16,000 | — | $0 | 16,000 | SEC↗ |
| PAREKH RAJESH B | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Johnson David Michael | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Mattessich Antony C. | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Rich Cadmus | See Remarks | A Award deriv | 2023-01-19 | 2023-01-23 | 52,500 | — | $0 | 52,500 | SEC↗ |
| de los Pinos Elisabet | See Remarks | A Award deriv | 2023-01-19 | 2023-01-23 | 187,500 | — | $0 | 187,500 | SEC↗ |
| De Rosch Mark | Chief Operating Officer | A Award deriv | 2023-01-19 | 2023-01-23 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Feder Julie B | Chief Financial Officer | A Award deriv | 2023-01-19 | 2023-01-23 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Rich Cadmus | See Remarks | A Award | 2023-01-19 | 2023-01-23 | 34,125 | — | $0 | 58,703 | SEC↗ |
| de los Pinos Elisabet | See Remarks | A Award | 2023-01-19 | 2023-01-23 | 121,875 | — | $0 | 190,526 | SEC↗ |
| De Rosch Mark | Chief Operating Officer | A Award | 2023-01-19 | 2023-01-23 | 42,250 | — | $0 | 58,635 | SEC↗ |
| Feder Julie B | Chief Financial Officer | A Award | 2023-01-19 | 2023-01-23 | 48,750 | — | $0 | 72,985 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-01-06 | 2023-01-09 | 700 | $10.50 | $7.3K | 18,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-01-06 | 2023-01-09 | 904 | $10.51 | $9.5K | 18,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-01-05 | 2023-01-09 | 96 | $10.00 | $960 | 17,096 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2023-01-05 | 2023-01-09 | 300 | $10.00 | $3.0K | 17,300 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2022-12-28 | 2022-12-30 | 2,000 | $9.75 | $19.5K | 17,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2022-12-28 | 2022-12-30 | 2,000 | $9.75 | $19.5K | 17,000 | SEC↗ |
| Matrix Capital Management Comp | 10% Owner | P Buy | 2022-12-05 | 2022-12-07 | 1,250,000 | $12.00 | $15.00M | 5,362,870 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2022-12-01 | 2022-12-15 | 5,000 | $12.37 | $61.8K | 15,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2022-12-01 | 2022-12-15 | 5,000 | $12.37 | $61.8K | 15,000 | SEC↗ |
| De Rosch Mark | Chief Operating Officer | S Sale | 2022-10-31 | 2022-11-02 | 1,115 | $12.46 | $13.9K | 16,385 | SEC↗ |
| de los Pinos Elisabet | See Remarks | S Sale | 2022-10-31 | 2022-11-02 | 5,706 | $12.46 | $71.1K | 68,651 | SEC↗ |
| Rich Cadmus | See Remarks | S Sale | 2022-10-31 | 2022-11-02 | 1,672 | $12.45 | $20.8K | 24,578 | SEC↗ |
| Feder Julie B | Chief Financial Officer | S Sale | 2022-10-31 | 2022-11-02 | 2,015 | $12.45 | $25.1K | 24,235 | SEC↗ |
| Mattessich Antony C. | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Srivastava Sapna | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Johnson David Michael | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 16,000 | — | $0 | 16,000 | SEC↗ |
| PAREKH RAJESH B | Director | A Award deriv | 2022-06-15 | 2022-06-17 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2022-06-13 | 2022-06-14 | 20,000 | $13.99 | $279.8K | 30,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2022-06-13 | 2022-06-14 | 7,000 | $13.99 | $97.9K | 10,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2022-06-13 | 2022-06-14 | 7,000 | $13.99 | $97.9K | 10,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2022-06-10 | 2022-06-14 | 10,000 | $15.04 | $150.4K | 10,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2022-06-10 | 2022-06-14 | 3,000 | $15.04 | $45.1K | 3,000 | SEC↗ |
| Johnson David Michael | Director | P Buy | 2022-06-10 | 2022-06-14 | 3,000 | $15.04 | $45.1K | 3,000 | SEC↗ |
| Johnson David Michael | Director | C Conversion deriv | 2021-11-02 | 2021-11-02 | 139,672 | — | $0 | 0 | SEC↗ |
| de los Pinos Elisabet | See Remarks | C Conversion deriv | 2021-11-02 | 2021-11-02 | 3,042 | — | $0 | 0 | SEC↗ |
| de los Pinos Elisabet | See Remarks | C Conversion deriv | 2021-11-02 | 2021-11-02 | 1,510 | — | $0 | 0 | SEC↗ |
| GOEL DAVID E. | 10% Owner | C Conversion deriv | 2021-11-02 | 2021-11-04 | 2,327,870 | — | $0 | 0 | SEC↗ |
| Medicxi Growth I LP | 10% Owner | C Conversion deriv | 2021-11-02 | 2021-11-04 | 251,545 | — | $0 | 0 | SEC↗ |
| Medicxi Growth I LP | 10% Owner | C Conversion deriv | 2021-11-02 | 2021-11-04 | 373,606 | — | $0 | 0 | SEC↗ |
| Medicxi Growth I LP | 10% Owner | C Conversion deriv | 2021-11-02 | 2021-11-04 | 1,650,676 | — | $0 | 0 | SEC↗ |
| Medicxi Growth I LP | 10% Owner | C Conversion deriv | 2021-11-02 | 2021-11-04 | 39,214 | — | $0 | 0 | SEC↗ |
| Medicxi Growth I LP | 10% Owner | C Conversion deriv | 2021-11-02 | 2021-11-04 | 5,975 | — | $0 | 0 | SEC↗ |
| Medicxi Growth I LP | 10% Owner | C Conversion deriv | 2021-11-02 | 2021-11-04 | 8,876 | — | $0 | 0 | SEC↗ |
| Johnson David Michael | Director | C Conversion | 2021-11-02 | 2021-11-02 | 139,672 | — | $0 | 139,672 | SEC↗ |
| de los Pinos Elisabet | See Remarks | C Conversion | 2021-11-02 | 2021-11-02 | 4,552 | — | $0 | 131,412 | SEC↗ |
| GOEL DAVID E. | 10% Owner | P Buy | 2021-11-02 | 2021-11-04 | 1,785,000 | $14.00 | $24.99M | 4,112,870 | SEC↗ |
| GOEL DAVID E. | 10% Owner | C Conversion | 2021-11-02 | 2021-11-04 | 2,327,870 | — | $0 | 2,327,870 | SEC↗ |
| Medicxi Growth I LP | 10% Owner | C Conversion | 2021-11-02 | 2021-11-04 | 54,065 | — | $0 | 54,065 | SEC↗ |
| Medicxi Growth I LP | 10% Owner | P Buy | 2021-11-02 | 2021-11-04 | 16,475 | $14.00 | $230.7K | 70,540 | SEC↗ |
| Medicxi Growth I LP | 10% Owner | C Conversion | 2021-11-02 | 2021-11-04 | 2,275,827 | — | $0 | 2,275,827 | SEC↗ |
| Medicxi Growth I LP | 10% Owner | P Buy | 2021-11-02 | 2021-11-04 | 693,525 | $14.00 | $9.71M | 2,969,352 | SEC↗ |
| Srivastava Sapna | Director | A Award deriv | 2021-10-28 | 2021-10-29 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Primiano Christopher Brett | Chief Business Officer | A Award deriv | 2021-10-28 | 2021-10-29 | 37,500 | — | $0 | 37,500 | SEC↗ |
| PAREKH RAJESH B | Director | A Award deriv | 2021-10-28 | 2021-10-29 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Feder Julie B | Chief Financial Officer | A Award deriv | 2021-10-28 | 2021-10-29 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Mattessich Antony C. | Director | A Award deriv | 2021-10-28 | 2021-10-29 | 16,000 | — | $0 | 16,000 | SEC↗ |
| De Rosch Mark | Chief Operating Officer | A Award deriv | 2021-10-28 | 2021-10-29 | 75,000 | — | $0 | 75,000 | SEC↗ |
| de los Pinos Elisabet | See Remarks | A Award deriv | 2021-10-28 | 2021-10-29 | 318,750 | — | $0 | 318,750 | SEC↗ |
| Rich Cadmus | See Remarks | A Award deriv | 2021-10-28 | 2021-10-29 | 112,500 | — | $0 | 112,500 | SEC↗ |
| Johnson David Michael | Director | A Award deriv | 2021-10-28 | 2021-10-29 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Primiano Christopher Brett | Chief Business Officer | A Award | 2021-10-28 | 2021-10-29 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Feder Julie B | Chief Financial Officer | A Award | 2021-10-28 | 2021-10-29 | 26,250 | — | $0 | 26,250 | SEC↗ |
| De Rosch Mark | Chief Operating Officer | A Award | 2021-10-28 | 2021-10-29 | 17,500 | — | $0 | 17,500 | SEC↗ |
| de los Pinos Elisabet | See Remarks | A Award | 2021-10-28 | 2021-10-29 | 74,357 | — | $0 | 74,357 | SEC↗ |
| Rich Cadmus | See Remarks | A Award | 2021-10-28 | 2021-10-29 | 26,250 | — | $0 | 26,250 | SEC↗ |